FGP
CL icon

Freestone Grove Partners’s Colgate-Palmolive CL Stock Holding History

Freestone Grove Partners’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,164,038
Closed -$92M – 1014
2025
Q4 		$92M Buy
+1,164,038
New +$91.3M 0.67% 18
2025
Q3 		– Sell
-19,805
Closed -$1.8M – 731
2025
Q2 		$1.8M Sell
19,805
-32,182
-62% -$2.94M 0.01% 381
2025
Q1 		$4.87M Buy
+51,987
New +$4.66M 0.05% 284

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Freestone Grove Partners's CL Position: Q1 2026 in Review

Freestone Grove Partners sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 1,164,038 shares — an estimated $92M sold.

Freestone Grove Partners first reported a position in CL in Q1 2025 and held it in 3 quarters. The position peaked at $92M in Q4 2025. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Freestone Grove Partners reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Freestone Grove Partners sold 1,164,038 Colgate-Palmolive shares in Q1 2026, an estimated $92M.
  • Freestone Grove Partners first reported a position in Colgate-Palmolive in Q1 2025 and held it in 3 quarters.
  • Freestone Grove Partners's Colgate-Palmolive position peaked at $92M in Q4 2025.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.